NBTX

Conviction 30HealthcareScan · Thu, Sep 24, 2026

Nanobiotix S.A. (NBTX) closed at $33.43 (-5.15%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 39, RS Rating 94, -39.3% from its 52-week high, +51.0% year to date. Sector: Healthcare · Biotechnology.

NBTX$33.43-5.15%

ResistanceSupportVol 14

Vol MA14 127.81K

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Nanobiotix S.A.Biotechnologywww.nanobiotix.com ↗

Price33.43

Change-5.15%

Gap-6.02%

Rel volume—

Avg volume139.47K

Avg $ vol5.31M

SMA 2037.44

SMA 5038.79

SMA 20033.15

Price vs 50-13.84%

Price vs 200+0.84%

MA stackmixed

50/200 cross—

Supertrenddown · 39.94

RSI (14)39

MACD hist-0.34

MACD cross—

Stoch %K / %D19 / 22

ADX (14)12

+DI / −DI20 / 33

RSI divergence—

MACD divergence—

ATR %7.28%

ADR %5.85%

52w high55.07

52w low14.75

From 52w high-39.30%

Above 52w low+126.61%

New 52w highNo

SqueezeOff

Bollinger width32.82%

%B0.17

Donchian pos12.09%

Donchian high46.69

Donchian low31.60

AVWAP (52w high)39.20

vs AVWAP high-14.73%

AVWAP (52w low)32.90

vs AVWAP low+1.58%

OBV trendDown

Chaikin MF (20)-0.11

Today vs 20d—

Avg vol (14d)127.81K

Avg vol (20d)139.47K

Avg $ vol (20d)5.31M

Market cap1.62B

RS Rating94 / 99

RS 3m (vs SPY)-7.41%

RS 6m (vs SPY)-7.69%

RS line new highNo

Trend template4/8

Technical rank39.2

1 week-6.84%

1 month-19.48%

3 months-2.92%

6 months+9.13%

1 year+131.31%

YTD+51.04%

P/E—

P/B—

P/S—

P/FCF—

EPS—

Div yield—

ROE—

ROA—

Debt/Eq—

Current—

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth—

Price target64.00

Target upside91.47%

Analyst ratingBuy

Institutional11.44%

Ent. value1.62B

Revenue—

Net income—

Gross profit—

Free cash flow—

IndustryBiotechnology

ExchangeNasdaq

Shares out50.81M

Employees97

ListedFri, Dec 11, 2020

Free float33.88M

Float %66.5%

Short interest149.22K

Days to cover0.7d

Short volume42.4%

Squeeze score6 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction30 / 100

Pattern quality—

Tech rank39.2 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance46.22

Support34.21

Days since event—

Candle confirm—

Congress activity

Disclosed STOCK Act trades in NBTX

All disclosures →

No recent disclosed trades by Congress in NBTX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NBTX

No recent insider (Form 4) filings in NBTX. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in NBTX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.

NBTX

Recent news

Get daily signals & real-time alerts.